hematoporphyrin has been researched along with Bone Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Hua, Y; Sun, M; Wang, Z; Yin, F; Zeng, H; Zhou, C | 1 |
| Leung, AW; Quan, X; Tian, Z; Xiang, J; Xu, C | 1 |
| Lu, SB | 1 |
3 other study(ies) available for hematoporphyrin and Bone Neoplasms
| Article | Year |
|---|---|
Hematoporphyrin monomethyl ether-mediated photodynamic therapy selectively kills sarcomas by inducing apoptosis.
Topics: Animals; Apoptosis; Bone Neoplasms; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Hematoporphyrins; Humans; Mice; NIH 3T3 Cells; Osteosarcoma; Photochemotherapy; Poly(ADP-ribose) Polymerases | 2013 |
Hematoporphyrin monomethyl ether enhances the killing of ultrasound on osteosarcoma cells involving intracellular reactive oxygen species and calcium ion elevation.
Topics: Bone Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Hematoporphyrins; Humans; Intracellular Space; Ions; Microscopy, Electron, Transmission; Osteosarcoma; Radiation-Sensitizing Agents; Radiofrequency Therapy; Reactive Oxygen Species; Ultrasonic Therapy; Up-Regulation | 2010 |
[Uses of a hematoporphyrin derivative for intra-operative localization of bone and soft tissue tumors].
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Femoral Neoplasms; Hematoporphyrin Derivative; Hematoporphyrins; Humans; Male; Middle Aged; Osteosarcoma; Rhabdomyosarcoma; Soft Tissue Neoplasms; Spectrometry, Fluorescence; Tibia | 1987 |